NovaBay Pharmaceuticals I... (NBY)
AMEX: NBY
· Real-Time Price · USD
0.55
-0.05 (-9.06%)
At close: Aug 15, 2025, 3:30 PM
0.62
13.30%
After-hours: Aug 15, 2025, 03:58 PM EDT
-9.06% (1D)
| Bid | 0.62 |
| Market Cap | 3.17M |
| Revenue (ttm) | 7.15M |
| Net Income (ttm) | 3.66M |
| EPS (ttm) | 24.38 |
| PE Ratio (ttm) | 0.02 |
| Forward PE | -1.58 |
| Analyst | Buy |
| Ask | 0.63 |
| Volume | 206,371 |
| Avg. Volume (20D) | 33,338 |
| Open | 0.57 |
| Previous Close | 0.60 |
| Day's Range | 0.55 - 0.57 |
| 52-Week Range | 0.44 - 1.01 |
| Beta | 0.41 |
Analyst Forecast
According to 0 analyst ratings, the average rating for NBY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
-1.9%
Shares of several biotechnology stocks are trading...
Unlock content with
Pro Subscription
9 months ago
+18.24%
NovaBay Pharmaceuticals shares are trading higher after the company announced it received an acquisition offer for up to $11.5 million, which is superior to the previous offer from a different entity.
